Insulin resistance in liver cirrhosis may depend on either reduced sensitivity (receptor defect) and/or reduced response to insulin (postreceptor defect). To clarify the mechanism of such resistance, a [3Hjglucose infusion (0.2
Introduction
Carbohydrate intolerance in cirrhosis of the liver has been extensively demonstrated (1) (2) (3) (4) (5) (6) (7) (8) , ever since Naunyn first coined Some parts of this study were presented at the 2nd International Symposium on Insulin Receptors, Rome, Italy, September 1983.
Received for publication 26 March 1984 and in revised form 14 January 1985. the term "hepatogenous diabetes" in 1906 (9). The simultaneous observation of hyperinsulinemia in both the fasting subject and after oral glucose loading (10, 1 1) has pointed to insulin resistance as classically defined by Yalow and Berson (12). Hyperinsulinism may be attributable to liver cell damage resulting in reduced insulin uptake (13) and/or to portosystemic shunt (14) (15) (16) , while insulin resistance may be the outcome of reduced sensitivity to insulin, whether hepatic (increased gluconeogenesis and glycogenolysis) or peripheral (17), and may occur at the receptor or postreceptor level (18) . Hyperglucagonemia (19, 20) , hypersomatotropinemia (21, 22) , and high levels of free fatty acids (23-25) have been suggested as potential explanations of this insulin resistance, though further investigation of this question is necessary. Greco et al. (26) have examined insulin resistance mechanisms in cirrhosis through the infusion of glucose-insulin-somatostatin. Their results show that insulin resistance is scarcely influenced by an increase in contrainsular hormones. Work on insulin binding to the target cells (27) (28) (29) primarily supports the view that insulin resistance is the consequence of a receptor defect. The present study was run because data showing the extent to which peripheral insulin resistance is due to postreceptor factors is lacking. Three objectives were sought: quantification of insulin resistance in compensated cirrhosis of the liver; assessment of the extent to which insulin resistance is receptoral rather than postreceptoral; and determination of how much of the postreceptor defect is ascribable to changes in the transcellular transport of glucose, which is the first step in the insulinstimulated metabolism of glucose, and is now open to study using relatively manageable techniques (30).
Methods
Subjects. Fourteen males and four females with cirrhosis of the liver, histologically confirmed by transcutaneous biopsy, were studied (Table  I) was kept at ±5% of the fasting value by automatic infusion of a 30% dextrose solution by means of a biostator (model GCIIS; Ames, Elkhart, IN), using operating mode 7:1 but allowing the operator to intervene manually on the optional glucose channel. The following constants were used: BD (blood glucose levels at which basal dextrose infusion started) = fasting glycemia +5%; QD (inverse of the static gain for dextrose infusion) = 45; RD (basal dextrose infusion rate) = 0.8 mg/kg, clamp at -100 M&U/ml, 2 mg/kg, clamp at -1,000 ,U/ ml, and 3 mg/kg, clamp at -10,000 ,uU/ml. The dextrose-infusing tube was replaced with a hemotransfusing apparatus (flow = 5 ml/ min; Baxter Laboratories, Morton Grove, IL). Constant infusion of 15 and 30 meq potassium aspartate/h accompanied the -1,000-and 10,000-MU/ml clamps, respectively. All blood samples were taken from the distal arm vein. A heat pad at 60°C was applied to the hand to arterialize the venous blood. Gas analysis of blood obtained in this way gave a Po2 of 89±4 mmHg. Analytical procedure. The glucose levels of blood automatically measured by the biostator were also checked on plasma every 5 min with a glucose analyzer (model II; Beckman Instruments, Inc., Fullerton, CA). Reproducibility was good (5% variation). studied on a 100-ml blood sample with 2 ml EDTA-Na2 from the fasting subjects. Mononucleated leukocytes were isolated by centrifugation on a density gradient according to the methods of Boyum (34) . For the competition studies, 40 X 106/ml cells were incubated in 100 mmol/liter Hepes (pH 8.0) for 100 min at 15°C with a tracer dose of 125I-insulin, and native insulin in increasing concentrations, followed by centrifugation through dibutyl-phtalate (d = 1.04) (35). Radioactivity bound to the cells in the presence of an excess of native insulin (10,000 ng/ml) was regarded as nonspecific and was subtracted from the total bound at each concentration point to calculate the specific binding value. Cell vitality was determined by exclusion of Trypan blue and it was always >97%. Monocytes were identified morphologically and cytochemically by the alpha-naphthylacetate esterase method. They formed 20±3% of the mononucleated leukocytes. The specific cell-binding fraction was adjusted to a mean concentration of monocytes of 107/ml.
Insulin binding to isolated adipocytes was also examined. Separation by digestion with collagenase and the binding study were done as previously described (36). Only total specific insulin binding at I ng/ ml insulin concentration was studied.
The transmembrane transport of glucose was studied according to the methods of Calculations. Basal endogenous glucose production (milligrams per kilogram per minute) was calculated by means of the isotopic dilution method, using Steele's formula (37) 
Results
Plasma glucose levels and insulin and dextrose infusion rates during the clamps are reported in Fig. 1 . The mean basal and steady state values are shown in Table II . Basal plasma glucose was much the same in both groups, whereas basal plasma insulin and C-peptide were significantly higher (P < 0.001 and <0.05, respectively) in the cirrhotics, and their molar Cpeptide/immunoreactive insulin (IRI) ratio was significantly lower at -100 (P < 0.001), 1,000 (P < 0.001), and 10,000 MU/ml (P < 0.05). Plasma C-peptide, endogenous glucose production, and glucose use in both groups at different insulinemic levels are illustrated in Fig. 2 . C-Peptide was significantly higher in the cirrhotics, both basally (P < 0.05) and during the steady state clamps (P < 0.001). In the controls, it was completely suppressed at -10,000 MU/ml, whereas suppression was only 57.5% of the baseline in the cirrhotics. Basal endogenous glucose production was 3.28±0.36 mg/kg per min in cirrhotics during the three clamps (P < 0.001 at -100 and 1,000 gU/ml; P < 0.05 at -10,000 MU/ml). A rightward shift of the dose-response curve is shown. Insulin binding to circulating monocytes is presented in the form of competition curve in Fig. 3 . Specifically bound radioactivity was significantly lower in the cirrhotics: 2.78±0.22 vs. 3.96±0.34% (P < 0.025).
Insulin binding to isolated adipocytes also showed a significant reduction in the cirrhotics: 2.52±0.30 vs. 3.88±0.46% (P < 0.025). 3-OMG transport values on isolated adipocytes were significantly lower in cirrhotics both in the basal state (P < 0.001) and at maximal insulin concentration (P < 0.05) (Fig. 4) .
Discussion
Basal plasma insulin levels were significantly higher in the cirrhotics, in keeping with enhanced secretion and/or reduced degradation of the hormone. Since C-peptide and insulin are Figure 2 . Plasma C-peptide under basal conditions ( 18 cirrhotics and 18 controls) and at the 120th min of hyperinsulinemic steady state (6 cirrhotics and 6 controls in each clamp). Glucose production and glucose use at different insulinemic levels. Cirrhotics (o), controls (-). , , released from the pancreas in equimolar amounts, and since liver metabolism of C-peptide appears to be negligible (39), plasma C-peptide can be used as the measurement of insulin secretion. Higher basal and during-clamp C-peptide levels in the cirrhotics point to enhanced B cell secretion. Kuhl et al. (40) have shown that C-peptide degradation takes place in the animal liver, though to a lesser extent than insulin (-50%). If also observed in man, this finding would be in conflict with the equimolar relationship between C-peptide levels and insulin secretion measurements, especially where liver function is altered. The C-peptide/IRI molar ratio was greatly reduced in the cirrhotics, suggesting that insulin degradation is even more seriously impaired. This interpretation agrees with Johnston et al.'s (10) data of reduced degradation as the cause of hyperinsulinemia in cirrhotics with basal C-peptide levels similar to those of controls.
In the cirrhotics we studied, basal hyperinsulinemia was accompanied by normal plasma glucose, resulting in an insulinresistant state attributable to increased endogenous production 1662 Cavallo-Perin et al. of glucose and/or its reduced peripheral use. The euglycemic clamp is used in vivo to determine whether insulin resistance is the result of reduced sensitivity, reduced responsiveness, or both, according to Kahn (18) . The euglycemic clamp has previously been used by us (41, 42) and by other investigators (17, 43) to study different forms of insulin resistance. In the cirrhotics we studied, a combined receptor and postreceptor defect may be deduced from the rightward shift of the doseresponse curve and the reduced maximum effect at the highest hyperinsulinemic level (Fig. 2) . It should be noted that reduced sensitivity to exogenous insulin is less apparent at -10,000 uU/ml. It may be that maximum receptor stimulation could have helped to reduce the difference in sensitivity between cirrhotics and controls. A similar lowering of sensitivity has recently been reported in elderly subjects by Rowe et al. (44) .
A reduced sensitivity to insulin suppression of glucose production was also measured in the cirrhotics we studied, 2 * though the maximum biologic effect was retained (almost complete inhibition at -10,000 gU/ml), even though the basal glucose production was not enhanced, suggesting an impairment of insulin modulation of the glucogenetic process. This phenomenon may be partly responsible for resistance, as suggested in a recent editorial by Olefsky (45) .
Insulin resistance could also be ascribed to the presence of abnormal insulins in the circulation (hyperproinsulinemia?) (46) . In our study, however, this view would be untenable, since reduced peripheral use of glucose was demonstrated through the intravenous infusion of exogenous human insulin.
Of (Fig. 3) show an -30% reduction in insulin binding to circulating monocytes. Insulin binding on isolated adipocytes, performed at one point only (1 ng/ml) of insulin concentration, confirmed our results on monocytes. All these data indicate that an insulin receptor impairment is present in liver cirrhosis, perhaps as a consequence of the down-regulation mechanism (49). To evaluate in vitro the postreceptor level, we studied the glucose transport on isolated adipocytes, as recently proposed by others (30).
Evaluation of the transmembrane transport of 3-OMG showed a significant reduction in the basal glucose uptake up to the maximum transport level (Fig. 4) . This finding is consistent with the existence of a defect in the initial step of insulin action on cirrhotic adipocytes, even if other steps distal from the receptor may also be involved. This phenomenon should be evaluated also in other target tissues, such as liver and muscle.
In conclusion, we believe that a combined receptor and postreceptor defect in insulin action on target cells is certainly an important cause of insulin resistance in cirrhosis of the liver. Insulin resistance may thus depend in part on the following sequence: decreased insulin degradation by the liver -hyperinsulinemia -down-regulation --insulinbinding decrease. An explanation remains to be found for the postreceptor alteration. Since the glucose transporter is a protein found in two cell pools (membrane and Golgi apparatus) ( 
